Concure Oncology raises $2.5M from ~25 investors to expand Breast Microseed radioactive-seed therapy

Concure Oncology raised $2.5 million from nearly 25 investors to expand adoption of its Breast Microseed Treatment, a brachytherapy that implants rice-grain-sized radioactive palladium seeds after tumor removal to kill remaining cancer cells. The Mercer Island startup has now secured over $12 million total and will use the round to double its field sales team and train clinicians nationwide.